Chinese herbal medicine may improve outcomes after STEMI
Por um escritor misterioso
Descrição
CHICAGO — A drug derived from traditional Chinese medicine as an adjunct to guideline-directed therapy improved CV outcomes at 30 days and 1 year compared with placebo after revascularization, with no excess bleeding risk, a speaker reported.“Despite reperfusion and optimal medical therapy, patients with STEMI still face a high risk of in-hospital mortality, myocardial no-flow and
Frontiers Bioactive Herbal Extracts of Traditional Chinese Medicine Applied with the Biomaterials: For the Current Applications and Advances in the Musculoskeletal System
Signaling pathways and targeted therapy for myocardial infarction
:max_bytes(150000):strip_icc()/what-are-adaptogens-4685073-primary-recirc-f5ef8698bc704b96ba54710b64fd7a0f.jpg)
Adaptogens: Types and Health Benefits
The utility of traditional Chinese medicine (Shenmai) in the cardiac rehabilitation after coronary artery bypass grafting: A single-center randomized clinical trial - ScienceDirect
Fractional Flow Reserve or Intravascular Ultrasonography to Guide PCI
Comparison of the modified Singapore myocardial infarction registry risk score with GRACE 2.0 in predicting 1-year acute myocardial infarction outcomes
Add-On Effect of Chinese Herbal Medicine on Mortality in Myocardial Infarction: Systematic Review and Meta-Analysis of Randomized Controlled Trials
Myocardial regeneration protocols towards the routine clinical scenario: An unseemly path from bench to bedside - eClinicalMedicine
The Pet Oncologist - Vet Oncologist Online - Chinese Herbs. Can It Treat Cancer In Dogs?
de
por adulto (o preço varia de acordo com o tamanho do grupo)
